Mixed model ANOVA analysis showed that the addition of tretinoin to αCTLA4 significantly delayed tumour growth compared both anti-CTLA-4 monotherapy (p=0.014) and tretinoin monotherapy (p<0.001). Here, CTLA4 is linked to neoplasm.